{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T13:34:08Z","timestamp":1786628048969,"version":"build-2736575974"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100016694","name":"Science and Technology Development Plan of Shandong Province","doi-asserted-by":"publisher","award":["252102311040"],"award-info":[{"award-number":["252102311040"]}],"id":[{"id":"10.13039\/100016694","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018925","name":"Health Commission of Henan Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013066","name":"Key Scientific Research Project of Colleges and Universities in Henan Province","doi-asserted-by":"publisher","award":["24A320063"],"award-info":[{"award-number":["24A320063"]}],"id":[{"id":"10.13039\/501100013066","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bbrc.2026.154040","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T23:30:54Z","timestamp":1779838254000},"page":"154040","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["BP-1-102 inhibits multiple pathways of NFATc1 activation to alleviate osteoporosis and downregulate osteoclast differentiation in ovariectomized mice"],"prefix":"10.1016","volume":"829","author":[{"given":"Jihao","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoli","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4231-358X","authenticated-orcid":false,"given":"Ji","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingxiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuge","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangnan","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.bbrc.2026.154040_bib1","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.ecl.2024.08.008","article-title":"Postmenopausal osteoporosis: a review of latest guidelines","volume":"53","author":"Subarajan","year":"2024","journal-title":"Endocrinol Metab. Clin. N. Am."},{"issue":"2","key":"10.1016\/j.bbrc.2026.154040_bib2","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/med.22081","article-title":"Estrogen deficiency-mediated osteoimmunity in postmenopausal osteoporosis","volume":"45","author":"Yao","year":"2025","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.bbrc.2026.154040_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102235","article-title":"Epigenetic regulations of cellular senescence in osteoporosis","volume":"99","author":"Huo","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.bbrc.2026.154040_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.788680","article-title":"Recent advances in osteoclast biological behavior","volume":"9","author":"Sun","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"42","key":"10.1016\/j.bbrc.2026.154040_bib5","doi-asserted-by":"crossref","first-page":"15395","DOI":"10.1074\/jbc.RA119.010139","article-title":"STAT3 controls osteoclast differentiation and bone homeostasis by regulating NFATc1 transcription","volume":"294","author":"Yang","year":"2019","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.bbrc.2026.154040_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0159891","article-title":"Methylsulfonylmethane inhibits RANKL-induced osteoclastogenesis in BMMs by suppressing NF-\u03baB and STAT3 activities","volume":"11","author":"Joung","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2026.154040_bib7","article-title":"Skeletal phenotype analysis of a conditional Stat3 deletion mouse model","volume":"161","author":"Yang","year":"2020","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.bbrc.2026.154040_bib8","article-title":"G\u03b1(q) modulates the energy metabolism of osteoclasts","volume":"12","author":"Chakraborty","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"11","key":"10.1016\/j.bbrc.2026.154040_bib9","doi-asserted-by":"crossref","first-page":"21182","DOI":"10.1002\/jcp.28721","article-title":"HIF-1\u03b1 facilitates osteocyte-mediated osteoclastogenesis by activating JAK2\/STAT3 pathway in vitro","volume":"234","author":"Zhu","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bbrc.2026.154040_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2025.156186","article-title":"Pharmacologically targeting fatty acid synthase-mediated de novo lipogenesis alleviates osteolytic bone loss by directly inhibiting osteoclastogenesis through suppression of STAT3 palmitoylation and ROS signaling","volume":"167","author":"Xiu","year":"2025","journal-title":"Metab., Clin. Exp."},{"issue":"16","key":"10.1016\/j.bbrc.2026.154040_bib11","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.2174\/0929867329666220819093117","article-title":"Discovery of STAT3 inhibitors: recent advances and future perspectives","volume":"30","author":"Song","year":"2023","journal-title":"Curr. Med. Chem."},{"issue":"4","key":"10.1016\/j.bbrc.2026.154040_bib12","first-page":"2698","article-title":"BP-1-102 exerts an antitumor effect on the AGS human gastric cancer cell line through modulating the STAT3 and MAPK signaling pathways","volume":"19","author":"Jiang","year":"2019","journal-title":"Mol. Med. Rep."},{"issue":"4","key":"10.1016\/j.bbrc.2026.154040_bib13","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s12013-022-01088-y","article-title":"Effects of STAT3 inhibitor BP-1-102 on the proliferation, invasiveness, apoptosis and neurosphere formation of glioma cells in vitro","volume":"80","author":"Zhang","year":"2022","journal-title":"Cell Biochem. Biophys."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154040_bib14","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.704","article-title":"Pharmacological inhibition of STAT3 by BP-1-102 inhibits intracranial aneurysm formation and rupture in mice through modulating inflammatory response","volume":"9","author":"Jiang","year":"2021","journal-title":"Pharmacol. Res. Perspect."},{"issue":"10","key":"10.1016\/j.bbrc.2026.154040_bib15","first-page":"2644","article-title":"STAT3 inhibition partly abolishes IL-33-Induced bone marrow-derived monocyte phenotypic transition into fibroblast precursor and alleviates experimental renal interstitial fibrosis","volume":"203","author":"Zhu","year":"1950","journal-title":"J. Immunolo. (Baltimore, Md"},{"issue":"5","key":"10.1016\/j.bbrc.2026.154040_bib16","doi-asserted-by":"crossref","first-page":"8561","DOI":"10.1002\/jcb.28143","article-title":"MicroRNA-543 promotes ovariectomy-induced osteoporosis through inhibition of AKT\/p38 MAPK signaling pathway by targeting YAF2","volume":"120","author":"Li","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bbrc.2026.154040_bib17","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/978-1-61779-415-5_3","article-title":"Rat osteoblast cultures","volume":"816","author":"Orriss","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bbrc.2026.154040_bib18","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/978-1-61779-415-5_8","article-title":"Rodent osteoclast cultures","volume":"816","author":"Orriss","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bbrc.2026.154040_bib19","article-title":"Lycorine suppresses RANKL-induced osteoclastogenesis in vitro and prevents ovariectomy-induced osteoporosis and titanium particle-induced osteolysis in vivo","volume":"5","author":"Chen","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2026.154040_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101309","article-title":"The Nrf2 activator RTA-408 attenuates osteoclastogenesis by inhibiting STING dependent NF-\u03bab signaling","volume":"28","author":"Sun","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/j.bbrc.2026.154040_bib21","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.intimp.2019.01.033","article-title":"Phenobarbital inhibits osteoclast differentiation and function through NF-\u03baB and MAPKs signaling pathway","volume":"69","author":"Wang","year":"2019","journal-title":"Int. Immunopharmacol."},{"issue":"3","key":"10.1016\/j.bbrc.2026.154040_bib22","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1097\/gme.0b013e3181d0f7f0","article-title":"Total extract and standardized fraction from the stem bark of Butea monosperma have osteoprotective action: evidence for the nonestrogenic osteogenic effect of the standardized fraction","volume":"17","author":"Pandey","year":"2010","journal-title":"Menopause (New York, N.Y.)"},{"issue":"11","key":"10.1016\/j.bbrc.2026.154040_bib23","doi-asserted-by":"crossref","first-page":"12929","DOI":"10.1096\/fj.201900887RR","article-title":"Octyl itaconate inhibits osteoclastogenesis by suppressing Hrd1 and activating Nrf2 signaling","volume":"33","author":"Sun","year":"2019","journal-title":"FASEB J."},{"key":"10.1016\/j.bbrc.2026.154040_bib24","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.intimp.2018.03.021","article-title":"Stattic inhibits RANKL-mediated osteoclastogenesis by suppressing activation of STAT3 and NF-\u03baB pathways","volume":"58","author":"Li","year":"2018","journal-title":"Int. Immunopharmacol."},{"issue":"5","key":"10.1016\/j.bbrc.2026.154040_bib25","doi-asserted-by":"crossref","first-page":"3819","DOI":"10.1002\/jcb.26332","article-title":"The participation of fibroblast growth factor 23 (FGF23) in the progression of osteoporosis via JAK\/STAT pathway","volume":"119","author":"Xu","year":"2018","journal-title":"J. Cell. Biochem."},{"issue":"2","key":"10.1016\/j.bbrc.2026.154040_bib26","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.bbrc.2016.01.048","article-title":"Niclosamide suppresses RANKL-induced osteoclastogenesis and prevents LPS-induced bone loss","volume":"470","author":"Cheon","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"7","key":"10.1016\/j.bbrc.2026.154040_bib27","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1182\/blood.V100.7.2530","article-title":"Heparin acts synergistically with interleukin-11 to induce STAT3 activation and in vitro osteoclast formation","volume":"100","author":"Walton","year":"2002","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.bbrc.2026.154040_bib28","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/jbmr.2612","article-title":"WHI-131 promotes osteoblast differentiation and prevents osteoclast formation and resorption in mice","volume":"31","author":"Cheon","year":"2016","journal-title":"J. Bone Miner. Res. : Off. J. Am. Soc. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154040_bib29","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12964-022-00924-1","article-title":"STAT3-mediated osteogenesis and osteoclastogenesis in osteoporosis","volume":"20","author":"Hou","year":"2022","journal-title":"Cell Commun. Signal. : CCS"},{"issue":"7","key":"10.1016\/j.bbrc.2026.154040_bib30","doi-asserted-by":"crossref","first-page":"3688","DOI":"10.1210\/en.2007-1719","article-title":"Interleukin-6 inhibits receptor activator of nuclear factor kappaB ligand-induced osteoclastogenesis by diverting cells into the macrophage lineage: key role of Serine727 phosphorylation of signal transducer and activator of transcription 3","volume":"149","author":"Duplomb","year":"2008","journal-title":"Endocrinology"},{"issue":"6","key":"10.1016\/j.bbrc.2026.154040_bib31","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/cbin.10771","article-title":"AG490 suppresses interleukin-34-mediated osteoclastogenesis in mice bone marrow macrophages","volume":"41","author":"Cheng","year":"2017","journal-title":"Cell Biol. Int."},{"issue":"10","key":"10.1016\/j.bbrc.2026.154040_bib32","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1182\/blood-2008-06-162594","article-title":"PIAS3 negatively regulates RANKL-mediated osteoclastogenesis directly in osteoclast precursors and indirectly via osteoblasts","volume":"113","author":"Hikata","year":"2009","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.bbrc.2026.154040_bib33","doi-asserted-by":"crossref","first-page":"5588","DOI":"10.4049\/jimmunol.178.9.5588","article-title":"Protein inhibitor of activated STAT 3 modulates osteoclastogenesis by down-regulation of NFATc1 and osteoclast-associated receptor","volume":"178","author":"Kim","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbrc.2026.154040_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2020.585056","article-title":"Osteoblast and osteoclast activity affect bone remodeling upon regulation by mechanical loading-induced leukemia inhibitory factor expression in osteocytes","volume":"7","author":"Du","year":"2020","journal-title":"Front. Mol. Biosci."},{"issue":"Pt 2","key":"10.1016\/j.bbrc.2026.154040_bib35","article-title":"VSIG4 inhibits RANKL-induced osteoclastogenesis by enhancing Nrf2-dependent antioxidant response against reactive oxygen species production","volume":"260","author":"Miao","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"issue":"37","key":"10.1016\/j.bbrc.2026.154040_bib36","doi-asserted-by":"crossref","first-page":"20383","DOI":"10.1021\/acs.jafc.4c02982","article-title":"Tetrahydroberberine prevents ovariectomy-induced bone loss by inhibiting RANKL-Induced osteoclastogenesis and promoting osteoclast apoptosis","volume":"72","author":"Wu","year":"2024","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.bbrc.2026.154040_bib37","first-page":"1","article-title":"Designed bone-targeting ROS-responsive nanoplatform for precision glycolysis inhibition in postmenopausal osteoporosis","volume":"58","author":"Wu","year":"2026","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.bbrc.2026.154040_bib38","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.2147\/NDT.S406782","article-title":"VSIG4 silencing inhibits glioblastoma growth by regulating the JAK2\/STAT3 pathway","volume":"19","author":"Zheng","year":"2023","journal-title":"Neuropsychiatric Dis. Treat."},{"key":"10.1016\/j.bbrc.2026.154040_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2024.578345","article-title":"V-set and immunoglobulin domain containing 4 inhibits oxidative stress, mitochondrial dysfunction, and inflammation to attenuate Parkinson's disease progression by activating the JAK2\/STAT3 pathway","volume":"391","author":"Cai","year":"2024","journal-title":"J. Neuroimmunol."},{"issue":"1","key":"10.1016\/j.bbrc.2026.154040_bib40","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1080\/14756366.2020.1871336","article-title":"Design, synthesis, and in vitro evaluation of BP-1-102 analogs with modified hydrophobic fragments for STAT3 inhibition","volume":"36","author":"Oleksak","year":"2021","journal-title":"J. Enzym. Inhib. Med. Chem."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26008041?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26008041?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T12:53:15Z","timestamp":1786625595000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X26008041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":40,"alternative-id":["S0006291X26008041"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154040","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BP-1-102 inhibits multiple pathways of NFATc1 activation to alleviate osteoporosis and downregulate osteoclast differentiation in ovariectomized mice","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"154040"}}